Gracell Biotechnologies I... (GRCL)

AI Score

Unlock

10.25

0.01 (0.05%)

At close: Feb 21, 2024, 9:00 PM

Gracell Biotechnologies Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q4 2019
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Dec 31, 2019
Cash & Equivalents	1.68B	-157.98M	1.27B	1.45B	1.43B	1.54B	1.62B	1.83B	1.95B	2.05B	2.16B	754.31M	156.78M	312.06M
Short-Term Investments	30.46M	3.57M	3.57M	3.56M	198.16M	172.2M	73.58M	3.62M	3.6M	3.73M	11.61M	18.74M	20.7M	4.2M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	7.04M	10.89M	11.76M	15.85M	18.51M	3.17M	27.86M	1.62M	22.24M	13.53M	19.9M	30.4M	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	30.96M	n/a	n/a
Inventory	n/a	1.7K	n/a	-26.33M	n/a	21.55M	n/a	8.7M	n/a	n/a	n/a	6.62M	8M	9.39M
Other Current Assets	66.4M	53.7M	47.53M	37.55M	40.34M	24.17M	66.6M	46.04M	60.93M	62.94M	54.9M	42.42M	34.06M	20.14M
Total Current Assets	1.77B	1.25B	1.32B	1.5B	1.67B	1.74B	1.76B	1.89B	2.02B	2.12B	2.22B	815.47M	215.7M	340.35M
Property-Plant & Equipment	108.67M	119.59M	137.06M	144.67M	149.91M	156.7M	144.08M	173.44M	156.15M	161.68M	143.81M	119.08M	124.92M	71.86M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	115.7M	130.48M	148.82M	160.52M	168.42M	159.87M	171.94M	175.06M	178.39M	175.21M	163.71M	149.48M	124.92M	71.86M
Total Assets	1.89B	1.38B	1.47B	1.66B	1.84B	1.9B	1.93B	2.06B	2.2B	2.29B	2.39B	964.95M	340.62M	412.22M
Account Payables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	62.46M	n/a	n/a	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	2.9M	n/a	2.9M	n/a	2.9M	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	80.45M	115.48M	136.53M	129.99M	146.8M	121.56M	104.97M	86M	75.97M	76.25M	77.11M	50.96M	20.24M	n/a
Other Current Liabilities	149.02M	78.34M	75.07M	90.65M	99.74M	92.64M	82.15M	6.66M	61.31M	55.62M	43.91M	42.4M	11.95M	18.17M
Total Current Liabilities	229.48M	193.82M	211.6M	220.64M	246.54M	217.1M	187.12M	155.12M	137.28M	131.87M	121.02M	93.36M	32.19M	18.17M
Long-Term Debt	35.37M	42.5M	46.09M	52.99M	56.98M	60.51M	65.92M	69.18M	74.44M	76.93M	61.52M	51.93M	44.64M	138.69M
Other Long-Term Liabilities	4.02M	4.85M	5.38M	6.88M	7.91M	7.76M	7.68M	8.46M	9.44M	10.1M	11.08M	n/a	n/a	n/a
Total Long-Term Liabilities	39.39M	47.35M	51.47M	59.87M	64.89M	68.27M	73.59M	77.64M	83.88M	87.04M	72.6M	51.93M	44.64M	138.69M
Total Liabilities	268.86M	241.17M	263.07M	280.51M	311.43M	285.38M	260.72M	232.77M	221.16M	218.91M	193.62M	145.29M	76.83M	156.86M
Total Debt	115.82M	157.98M	182.62M	182.98M	203.78M	182.07M	170.89M	155.18M	150.42M	153.19M	138.63M	102.89M	64.88M	138.69M
Common Stock	324K	225K	223K	223K	223K	223K	223K	223K	223K	222K	222K	68K	144K	68K
Retained Earnings	-1.99B	-1.92B	-1.78B	-1.63B	-1.49B	-1.32B	-1.18B	-1.02B	-889.19M	-759.9M	-663.68M	-564.03M	-464.1M	-289.4M
Comprehensive Income	113.94M	118.09M	55.65M	73.53M	98.71M	17.66M	-64.37M	-57.94M	-27.71M	-35.05M	-284K	-23.91M	-5.12M	-3.16M
Shareholders Equity	1.62B	1.14B	1.21B	1.38B	1.53B	1.61B	1.67B	1.83B	1.98B	2.07B	2.19B	819.66M	263.79M	255.36M
Total Investments	30.46M	3.57M	3.57M	3.56M	198.16M	172.2M	73.58M	3.62M	3.6M	3.73M	11.61M	18.74M	20.7M	4.2M